Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AACR, accretion, aggressive, AgreementSM, amplified, ampullary, ASCO, attained, Avastin, Ayala, BPCIA, cardiac, cisplatin, Clearance, cleavage, Concurrent, confirmatory, count, COVID, CRC, cytopenia, DCR, Dependingon, downturn, durvalumab, Expedite, expedited, extrahepatic, faster, FDORA, FOLFOX, gallbladder, gemcitabine, GI, healing, hemorrhage, Imfinzi, IMM, immunotherapy, inflationary, inhibitory, intrahepatic, IRA, JDC, lawsuit, Lonsurf, mesothelioma, mg, MOA, monkey, MSD, NCT, neuroendocrine, neutrophil, node, Notch, OS, oxaliplatin, paper, perforation, PFS, PIPE, PK, platelet, quickly, randomized, rationale, readout, recipient, recurrent, refractory, resting, Seoul, shape, shrinkage, Society, Stivarga, subset, superfamily, supplementary, swimmer, Symposium, TCJA, tipiracil, TRAE, trifluridine, UK, VEGF, VEGR, wound
Removed:
composition, consummation, noted, occurred, par, twelve, undertaken
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view